MedPath

MEDEX

🇫🇷France
Ownership
-
Established
1988-01-01
Employees
-
Market Cap
-
Website
http://medexbyguerbet.com/

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

1

FDA:1

Drug Approvals

Oxygen

Approval Date
Dec 8, 2021
FDA

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (100.0%)

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Phase 3
Conditions
Hiv Infection With Antiretroviral Therapy Indication
CD4 Below 350/µL or Below 15%
First Posted Date
2005-09-20
Last Posted Date
2005-12-16
Lead Sponsor
MEDEX
Target Recruit Count
250
Registration Number
NCT00199979
Locations
🇫🇷

Cisih, Clinique Medical A, Hopitaux Universitaires, Strasbourg, Alsace, France

News

No news found
© Copyright 2025. All Rights Reserved by MedPath